UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024		24,875,587
Beginning balance at Dec. 31, 2024	$ (33,415)	$ 2	$ 752,649	$ (786,066)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		108,072
Issuance of common stock	139		139
Stock-based compensation costs	529		529
Voluntary surrender of shares by shareholder (in shares)		(301)
Net loss	(11,759)			(11,759)
Ending balance (in shares) at Mar. 31, 2025		24,983,358
Ending balance at Mar. 31, 2025	$ (44,506)	$ 2	753,317	(797,825)
Beginning balance (in shares) at Dec. 31, 2025	83,025,384	83,025,384
Beginning balance at Dec. 31, 2025	$ 213,695	$ 8	1,040,417	(826,730)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of warrants (in shares)		8,206,833
Exercise of warrants	43,458	$ 1	43,457
Stock-based compensation costs	19,130		19,130
Taxes withheld related to net share settlement of equity awards	(4,197)		(4,197)
Vesting of restricted stock units (in shares)		128,384
Net loss	$ (48,287)			(48,287)
Ending balance (in shares) at Mar. 31, 2026	91,360,601	91,360,601
Ending balance at Mar. 31, 2026	$ 223,799	$ 9	$ 1,098,807	$ (875,017)